Protecting a blockbuster diabetes treatment for AstraZeneca
AstraZeneca AB
Major victories across IP venues for Volkswagen, Audi, Bentley, and Lamborghini
Audi AG; Audi of America, LLC; Automobili Lamborghini America, LLC; Automobili Lamborghini S.p.A.; Bentley Motors Limited; Bentley Motors, Inc; Volkswagen AG; Volkswagen Group of America, Inc.
No confusion in trademark victory on summary judgment for the American Retirement Association
American Retirement Association
Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million
Intellia Therapeutics, Inc.
Finnegan secures favorable ITC ruling related to innovative electric SUVs for BMW
BMW of North America, LLC and Bayerische Motoren Werke AG
Finnegan fights for Sony’s “exceedingly famous” mark
Sony Group Corporation
Experience
Sandoz Inc. v. Boehringer Ingelheim International GmbH et al. Sandoz Inc. v. Boehringer Ingelheim International GmbH et al.
PGR2022-00037, PTAB, Judges Newman, Obermann, Worth
Experience
Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million
Intellia Therapeutics, Inc.
Experience
AbbVie Inc. et al v. Alvotech hf. AbbVie Inc. et al v. Alvotech hf.
1:21-cv-02258, 1:21-cv-02899, N.D. Ill., Judge Lee
Experience
Regenxbio, Inc. et al. v. Sarepta Therapeutics, Inc. et al. Regenxbio, Inc. et al. v. Sarepta Therapeutics, Inc. et al.
1:20-cv-01226, D. Del., Judge Andrews
Experience
Teva Pharmaceuticals International GmbH v. Eli Lilly and Company Teva Pharmaceuticals International GmbH v. Eli Lilly and Company
2020-1747, -1748, -1749, -1750, -1751, -1752, -1876, -1877, -1878, Fed. Cir.
Experience
Sandoz, Inc. et al v. Pharmacyclics LLC Sandoz, Inc. et al v. Pharmacyclics LLC
IPR2019-00865, PTAB, Judges Cotta, Snedden, Mitchell
Experience
Eli Lilly and Company v. Teva Pharmaceuticals International Eli Lilly and Company v. Teva Pharmaceuticals International
IPR2018-01422; -01423; -01424; -01425; -01426; -01427; -01710, -01711, -01712, PTAB
Experience
Finnegan client AbbVie secures non-institution decisions for Humira® patents Finnegan client AbbVie secures non-institution decisions for Humira® patents
IPR2018-01987, -01988, PTAB, Judges Ankenbrand, Harlow, Mitchell
Experience
AbbVie Inc. v. Sandoz Inc. AbbVie Inc. v. Sandoz Inc.
3:18-cv-12668, D.N.J., Judge Wolfson
Experience
Sandoz Inc. v. AbbVie Biotechnology, Ltd Sandoz Inc. v. AbbVie Biotechnology, Ltd
IPR2018-00002, -00156, IPR2017 -01824, -02106, -02105, PTAB, Judges Ankenbrand, Hulse, Mitchell
Experience
Teva Pharmaceuticals International GmbH v. Eli Lilly and Company Teva Pharmaceuticals International GmbH v. Eli Lilly and Company
1:18-cv-12029, D. Mass., Judge Burroughs
Experience
AbbVie secures four non-institution decisions for Humira® patent AbbVie secures four non-institution decisions for Humira® patent
IPR2017-00822, -00823, -01008, -01009, PTAB, Judges Ankenbrand, Hulse, Mitchell
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.